{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T18:45:29Z","timestamp":1772131529576,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1208\/pt060476","type":"journal-article","created":{"date-parts":[[2006,1,6]],"date-time":"2006-01-06T21:41:17Z","timestamp":1136583677000},"page":"E618-E625","source":"Crossref","is-referenced-by-count":63,"title":["Adsorption of meloxicam on porous calcium silicate: Characterization and tablet formulation"],"prefix":"10.1208","volume":"6","author":[{"given":"Sameer","family":"Sharma","sequence":"first","affiliation":[]},{"given":"Praveen","family":"Sher","sequence":"additional","affiliation":[]},{"given":"Shraddha","family":"Badve","sequence":"additional","affiliation":[]},{"given":"Atmaram P.","family":"Pawar","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"64618_CR1","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1023\/A:1016212804288","volume":"12","author":"GL Amidon","year":"1995","unstructured":"Amidon GL, Lennern\u00e4s H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability.Pharm Res. 1995; 12:413\u2013420.","journal-title":"Pharm Res"},{"key":"64618_CR2","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1002\/jps.10555","volume":"93","author":"F Meriani","year":"2004","unstructured":"Meriani F, Coceani N, Sirotti C, Voinovich D, Grassi M. In vitro nimesulide absorption from different formulations.J Pharm Sci. 2004;93:540\u2013552.","journal-title":"J Pharm Sci"},{"key":"64618_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ijpharm.2004.09.007","volume":"288","author":"M Perrut","year":"2005","unstructured":"Perrut M, Jung J, Leboeuf F. Enhancement of dissolution rate of poorly-soluble active ingredients by supercritical fluid processes Part I. Micronization of neat particles.Int J Pharm. 2005;288:3\u201310.","journal-title":"Int J Pharm"},{"key":"64618_CR4","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/jps.10026","volume":"91","author":"M Kinoshita","year":"2002","unstructured":"Kinoshita M, Baba K, Nagayasu A, et al. Improvement of solubility and oral bioavailability of a poorly water-soluble drug, TAS-301, by its melt-adsorption on a porous calcium silicate.J Pharm Sci. 2002; 91:362\u2013370.","journal-title":"J Pharm Sci"},{"key":"64618_CR5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ijpharm.2004.06.009","volume":"282","author":"AA Ambike","year":"2004","unstructured":"Ambike AA, Mahadik KR, Paradkar A. Stability study of amorphous valdecoxib.Int J Pharm. 2004;282:151\u2013162.","journal-title":"Int J Pharm"},{"key":"64618_CR6","first-page":"150","volume":"63","author":"KPR Chowdary","year":"2001","unstructured":"Chowdary KPR, Hymavathi R. Enhancement of dissolution rate of meloxicam.Ind J Pharm Sci. 2001;63:150\u2013154.","journal-title":"Ind J Pharm Sci"},{"key":"64618_CR7","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1081\/PDT-200035804","volume":"9","author":"I Smirnova","year":"2004","unstructured":"Smirnova I, Suttiruengwong S, Seiler M, Arlt W. Dissolution rate enhancement by adsorption of poorly soluble drugs on hydrophilic silica aerogels.Pharm Dev Technol. 2004;9:443\u2013452.","journal-title":"Pharm Dev Technol"},{"key":"64618_CR8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0928-0987(02)00223-3","volume":"18","author":"A Streubel","year":"2003","unstructured":"Streubel A, Siepmann J, Bodmeier R. Floating matrix tablet based on low density foam powder: effects of formulation and processing parameters on drug release.Eur J Pharm Sci. 2003;18:37\u201345.","journal-title":"Eur J Pharm Sci"},{"key":"64618_CR9","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1248\/cpb.44.1361","volume":"44","author":"H Yuasa","year":"1996","unstructured":"Yuasa H, Takashima Y, Kanaya Y. Studies on the development of intragastric floating and sustained release preparation. I. Application of calcium silicate as a floating carrier.Chem Pharm Bull (Tokyo). 1996;44:1361\u20131366.","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"64618_CR10","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0378-5173(02)00241-7","volume":"241","author":"A Streubel","year":"2002","unstructured":"Streubel A, Siepmann J, Bodmeier R. Floating microparticles based on low density foam powder.Int J Pharm. 2002;241:279\u2013292.","journal-title":"Int J Pharm"},{"key":"64618_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ijpharm.2004.10.010","volume":"289","author":"Y Ito","year":"2005","unstructured":"Ito Y, Arai H, Uchino K, Iwasaki K, Shibata N, Takada K. Effect of adsorbents on the absorption of lansoprazole with surfactant.Int J Pharm. 2005;289:69\u201377.","journal-title":"Int J Pharm"},{"key":"64618_CR12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1381-1177(03)00112-7","volume":"24\u201325","author":"A Salis","year":"2003","unstructured":"Salis A, Sanjust E, Solinas V, Monduzzi M. Characterization of Accurel MP 1004 polypropylene powder and its use as a support for lipase immobilization.J Mol Cat B Enz. 2003;24\u201325:75\u201382.","journal-title":"J Mol Cat B Enz"},{"key":"64618_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0378-5173(02)00357-5","volume":"246","author":"RS Byrne","year":"2002","unstructured":"Byrne RS, Deasy PB. Use of commercial porous ceramic particles for sustained drug delivery.Int J Pharm. 2002;246:61\u201373.","journal-title":"Int J Pharm"},{"key":"64618_CR14","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1248\/cpb.42.2327","volume":"42","author":"H Yuasa","year":"1994","unstructured":"Yuasa H, Asahi D, Takashima Y, Kanaya Y, Shinozawa K. Application of calcium silicate for medicinal preparation. I. Solid preparation adsorbing an oily medicine to calcium silicate.Chem Pharm Bull (Tokyo). 1994;42:2327\u20132331.","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"64618_CR15","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1248\/cpb.44.378","volume":"44","author":"H Yuasa","year":"1996","unstructured":"Yuasa H, Akutagawa M, Hashizume T, Kanaya Y. Studies on internal structure of tablets. VI. Stress dispersion in tablets by excipients.Chem Pharm Bull (Tokyo). 1996;44:378\u2013382.","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"64618_CR16","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1081\/DDC-120018641","volume":"29","author":"M Kinoshita","year":"2003","unstructured":"Kinoshita M, Baba K, Nagayasu A, et al. Highly stabilized amorphous 3-bis(4-methoxyphenyl)methylene-2-indolinone (TAS-301) in melt-adsorbed products with silicate compounds.Drug Dev Ind Pharm. 2003;29:523\u2013529.","journal-title":"Drug Dev Ind Pharm"},{"key":"64618_CR17","first-page":"713","volume-title":"Goodman & Gilman\u2019s The Pharmacological Basis of Therapeutics","author":"RL Jackson","year":"2000","unstructured":"Jackson RL, Jason MD. Analgesic-antipyretic and anti-inflammatory agents and drugs employed in the treatment of gout. In: Hardman JG, Limbird LE, eds.Goodman & Gilman\u2019s The Pharmacological Basis of Therapeutics. New York, NY: McGraw-Hill; 2000:713\u2013714."},{"key":"64618_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jpba.2004.01.003","volume":"35","author":"NB Naidu","year":"2004","unstructured":"Naidu NB, Chowdary KP, Murthy KV, Satyanarayana V, Hayman AR, Becket G. Physicochemical characterization and dissolution properties of meloxicam-cyclodextrin binary systems.J Pharm Biomed Anal. 2004;35:75\u201386.","journal-title":"J Pharm Biomed Anal"},{"key":"64618_CR19","doi-asserted-by":"publisher","first-page":"E59","DOI":"10.1208\/pt050459","volume":"5","author":"MM Ghorab","year":"2004","unstructured":"Ghorab MM, Abdel-Salem HM, El-Sayad MA, Mekhel MM. Tablet formulation containing meloxicam and \u03b2-cyclodextrin: mechanical characterization and bioavailability evaluation.AAPS PharmSciTech. 2004;5:E59.","journal-title":"AAPS PharmSciTech"},{"key":"64618_CR20","doi-asserted-by":"publisher","first-page":"E33","DOI":"10.1208\/pt040333","volume":"4","author":"N Seedher","year":"2003","unstructured":"Seedher N, Bhatia S. Solubility enhancement of Cox-2 inhibitors using various solvent systems.AAPS PharmSciTech. 2003;4:E33.","journal-title":"AAPS PharmSciTech"},{"key":"64618_CR21","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1002\/jps.10207","volume":"91","author":"RG Cantera","year":"2002","unstructured":"Cantera RG, Leza MG, Bachiller CM. Solid phases of tenoxicam.J Pharm Sci. 2002;91:2240\u20132251.","journal-title":"J Pharm Sci"},{"key":"64618_CR22","unstructured":"International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use.ICH Harmonised Tripartite Guideline. Impurities: guideline for residual solvents Q3C. Geneva, Switzerland: ICH; 1997."},{"key":"64618_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","volume":"13","author":"P Costa","year":"2001","unstructured":"Costa P, Lobo JMS. Modeling and comparison of dissolution profiles.Eur J Pharm Sci. 2001;13:123\u2013133.","journal-title":"Eur J Pharm Sci"},{"key":"64618_CR24","first-page":"77","volume":"3","author":"S Charumanee","year":"2004","unstructured":"Charumanee S, Okonoki S, Sirithunyalug J. Improvement of the dissolution rate of piroxicam by surface solid dispersion.CMU J. 2004;3:77\u201384.","journal-title":"CMU J"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/pt060476.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/pt060476\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/pt060476.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/pt060476","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T03:42:05Z","timestamp":1559619725000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/pt060476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["64618"],"URL":"https:\/\/doi.org\/10.1208\/pt060476","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}